ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,056,596 shares; 2025Q1: 6,056,596 shares; 2025Q2: 6,056,596 shares; 2025Q3: 7,111,596 shares; 2025Q4: 7,111,596 shares; 2026Q1: 6,481,085 shares; 2026Q2: 6,007,834 shares; 2026Q3: 3,663,038 shares 3,663,038 $363M 10.25% -2,344,796 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,670,206 shares; 2025Q1: 3,670,206 shares; 2025Q2: 3,670,206 shares; 2025Q3: 3,670,206 shares; 2025Q4: 3,670,206 shares; 2026Q1: 3,670,206 shares; 2026Q2: 3,670,206 shares; 2026Q3: 3,670,206 shares 3,670,206 $260M 7.35% 0 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,643,812 shares; 2025Q1: 5,943,812 shares; 2025Q2: 5,943,812 shares; 2025Q3: 6,243,812 shares; 2025Q4: 6,243,812 shares; 2026Q1: 6,243,812 shares; 2026Q2: 6,243,812 shares; 2026Q3: 6,243,812 shares 6,243,812 $182M 5.13% 0 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,100,582 shares; 2025Q4: 1,900,582 shares; 2026Q1: 1,900,582 shares; 2026Q2: 1,900,582 shares; 2026Q3: 1,900,582 shares 1,900,582 $169M 4.78% 0 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,736,000 shares; 2025Q1: 10,736,000 shares; 2025Q2: 10,736,000 shares; 2025Q3: 8,536,196 shares; 2025Q4: 12,762,094 shares; 2026Q1: 10,531,071 shares; 2026Q2: 9,081,201 shares; 2026Q3: 6,773,043 shares 6,773,043 $169M 4.77% -2,308,158 Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 6,137,627 shares; 2026Q3: 6,229,081 shares 6,229,081 $164M 4.64% +91,454 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,660,933 shares; 2026Q1: 4,457,988 shares; 2026Q2: 4,457,988 shares; 2026Q3: 4,457,988 shares 4,457,988 $151M 4.25% 0 Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,501,624 shares; 2025Q1: 1,501,624 shares; 2025Q2: 1,501,624 shares; 2025Q3: 1,676,624 shares; 2025Q4: 1,676,624 shares; 2026Q1: 1,676,624 shares; 2026Q2: 1,676,624 shares; 2026Q3: 1,676,624 shares 1,676,624 $148M 4.17% 0 Timeline KRSA KORSANA BIOSCIENCES INC More: the full row for KORSANA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,549,587 shares 4,549,587 $146M 4.11% new Timeline KOD KODIAK SCIENCES INC More: the full row for KODIAK SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,145,538 shares; 2025Q1: 1,145,538 shares; 2025Q2: 1,145,538 shares; 2025Q3: 1,145,538 shares; 2025Q4: 1,445,538 shares; 2026Q1: 1,445,538 shares; 2026Q2: 1,445,538 shares; 2026Q3: 1,445,538 shares 1,445,538 $137M 3.87% 0 Timeline VOR VOR BIOPHARMA INC More: the full row for VOR BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,673,078 shares; 2026Q2: 5,673,078 shares; 2026Q3: 5,673,078 shares 5,673,078 $108M 3.06% 0 Timeline TRAX FIRST TRACKS BIOTHERAPEUTICS More: the full row for FIRST TRACKS BIOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 2,895,304 shares; 2026Q3: 2,895,304 shares 2,895,304 $103M 2.9% 0 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 62,049 shares; 2026Q1: 1,062,049 shares; 2026Q2: 1,062,049 shares; 2026Q3: 1,118,967 shares 1,118,967 $95.6M 2.7% +56,918 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,020,968 shares; 2026Q2: 11,020,968 shares; 2026Q3: 11,020,968 shares 11,020,968 $91.8M 2.59% 0 Timeline IRON DISC MEDICINE INC More: the full row for DISC MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 486,957 shares; 2025Q1: 465,257 shares; 2025Q2: 465,257 shares; 2025Q3: 465,257 shares; 2025Q4: not reported; 2026Q1: 1,341,862 shares; 2026Q2: 1,341,862 shares; 2026Q3: 1,341,862 shares 1,341,862 $87.8M 2.48% 0 Timeline ADRX ADARX PHARMACEUTICALS INC More: the full row for ADARX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 4,116,452 shares 4,116,452 $82.1M 2.32% new Timeline COGT COGENT BIOSCIENCES INC More: the full row for COGENT BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,964,375 shares; 2025Q1: 6,964,375 shares; 2025Q2: 6,964,375 shares; 2025Q3: 6,798,162 shares; 2025Q4: 5,868,162 shares; 2026Q1: 4,946,894 shares; 2026Q2: 4,854,436 shares; 2026Q3: 2,500,003 shares 2,500,003 $80.1M 2.26% -2,354,433 Timeline TYRA TYRA BIOSCIENCES INC More: the full row for TYRA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,989,103 shares; 2025Q1: 2,898,103 shares; 2025Q2: 2,898,103 shares; 2025Q3: 2,898,103 shares; 2025Q4: 2,898,103 shares; 2026Q1: 3,248,980 shares; 2026Q2: 3,248,980 shares; 2026Q3: 3,475,980 shares 3,475,980 $76M 2.15% +227,000 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,650,150 shares; 2025Q1: 2,650,150 shares; 2025Q2: 3,766,660 shares; 2025Q3: 4,615,144 shares; 2025Q4: 4,615,144 shares; 2026Q1: 4,615,144 shares; 2026Q2: 4,615,144 shares; 2026Q3: 4,615,144 shares 4,615,144 $74.3M 2.1% 0 Timeline RLAY RELAY THERAPEUTICS INC More: the full row for RELAY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,810,351 shares; 2025Q4: 3,220,186 shares; 2026Q1: 4,273,356 shares; 2026Q2: 4,273,356 shares; 2026Q3: 3,783,529 shares 3,783,529 $68.3M 1.93% -489,827 Timeline AURA AURA BIOSCIENCES INC More: the full row for AURA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 9,533,333 shares; 2026Q3: 10,165,357 shares 10,165,357 $63.8M 1.8% +632,024 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 12,362,205 shares; 2025Q1: 12,362,205 shares; 2025Q2: 12,362,205 shares; 2025Q3: 12,362,205 shares; 2025Q4: 12,362,205 shares; 2026Q1: 12,362,205 shares; 2026Q2: 12,362,205 shares; 2026Q3: 12,362,205 shares 12,362,205 $63.8M 1.8% 0 Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,452,138 shares; 2025Q1: 2,452,138 shares; 2025Q2: 2,452,138 shares; 2025Q3: 2,452,138 shares; 2025Q4: 2,452,138 shares; 2026Q1: 2,452,138 shares; 2026Q2: 2,452,138 shares; 2026Q3: 2,055,938 shares 2,055,938 $51.3M 1.45% -396,200 Timeline AVTX AVALO THERAPEUTICS INC More: the full row for AVALO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 483,000 shares; 2025Q1: 483,000 shares; 2025Q2: 483,000 shares; 2025Q3: 483,000 shares; 2025Q4: 483,000 shares; 2026Q1: 738,383 shares; 2026Q2: 3,017,120 shares; 2026Q3: 3,017,120 shares 3,017,120 $46.3M 1.31% 0 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,622,151 shares; 2026Q1: 4,622,151 shares; 2026Q2: 4,622,151 shares; 2026Q3: 3,781,532 shares 3,781,532 $45.1M 1.27% -840,619 Timeline MBX MBX BIOSCIENCES INC More: the full row for MBX BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 650,000 shares; 2025Q1: 650,000 shares; 2025Q2: 650,000 shares; 2025Q3: 650,000 shares; 2025Q4: 650,000 shares; 2026Q1: 650,000 shares; 2026Q2: 650,000 shares; 2026Q3: 650,000 shares 650,000 $38.1M 1.08% 0 Timeline ENTX ENTERA BIO LTD More: the full row for ENTERA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,254,901 shares 12,254,901 $35.7M 1.01% new Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,789,617 shares; 2026Q1: 1,789,617 shares; 2026Q2: 1,789,617 shares; 2026Q3: 1,789,617 shares 1,789,617 $30.9M 0.87% 0 Timeline TARS TARSUS PHARMACEUTICALS INC More: the full row for TARSUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 388,164 shares 388,164 $30.5M 0.86% new Timeline IPSC CENTURY THERAPEUTICS INC More: the full row for CENTURY THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,754,430 shares; 2026Q2: 17,754,430 shares; 2026Q3: 17,754,430 shares 17,754,430 $30.4M 0.86% 0 Timeline OBX OBSIDIAN THERAPEUTICS INC More: the full row for OBSIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 2,196,138 shares 2,196,138 $30.2M 0.85% new Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,008,229 shares; 2026Q3: 947,544 shares 947,544 $30.1M 0.85% -60,685 Timeline LBRX LB PHARMACEUTICALS INC More: the full row for LB PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,745,016 shares; 2025Q4: 1,745,015 shares; 2026Q1: 1,839,489 shares; 2026Q2: 1,447,310 shares; 2026Q3: 765,050 shares 765,050 $29.4M 0.83% -682,260 Timeline EDIT EDITAS MEDICINE INC More: the full row for EDITAS MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,111,111 shares; 2026Q3: 11,111,111 shares 11,111,111 $28.6M 0.81% 0 Timeline TECX TECTONIC THERAPEUTIC INC More: the full row for TECTONIC THERAPEUTIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,204,891 shares; 2026Q2: 1,204,891 shares; 2026Q3: 1,204,891 shares 1,204,891 $28.1M 0.79% 0 Timeline IFRX INFLARX NV More: the full row for INFLARX NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 14,500,000 shares; 2026Q3: 14,500,000 shares 14,500,000 $26.1M 0.74% 0 Timeline CATX PERSPECTIVE THERAPEUTICS INC More: the full row for PERSPECTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 7,915,567 shares; 2026Q2: 7,915,567 shares; 2026Q3: 7,915,567 shares 7,915,567 $21.8M 0.61% 0 Timeline AGMB AGOMAB THERAPEUTICS NV More: the full row for AGOMAB THERAPEUTICS NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,053,233 shares; 2026Q2: 2,053,233 shares; 2026Q3: 1,820,831 shares 1,820,831 $20.2M 0.57% -232,402 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,033,560 shares; 2025Q1: 3,033,560 shares; 2025Q2: 3,033,560 shares; 2025Q3: 3,033,560 shares; 2025Q4: 3,033,560 shares; 2026Q1: 3,033,560 shares; 2026Q2: 3,033,560 shares; 2026Q3: 1,819,035 shares 1,819,035 $19.9M 0.56% -1,214,525 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,000,000 shares; 2026Q1: 10,000,000 shares; 2026Q2: 10,000,000 shares; 2026Q3: 10,000,000 shares 10,000,000 $18.5M 0.52% 0 Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,631,317 shares; 2026Q1: 4,631,317 shares; 2026Q2: 1,779,952 shares; 2026Q3: 1,262,423 shares 1,262,423 $16.9M 0.48% -517,529 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 153,000 shares; 2025Q4: 141,915 shares; 2026Q1: 132,103 shares; 2026Q2: 203,327 shares; 2026Q3: 202,242 shares 202,242 $16.1M 0.46% -1,085 Timeline ADCT ADC THERAPEUTICS SA More: the full row for ADC THERAPEUTICS SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,390,175 shares; 2025Q4: 11,390,175 shares; 2026Q1: 11,390,175 shares; 2026Q2: 11,390,175 shares; 2026Q3: 11,390,175 shares 11,390,175 $13.9M 0.39% 0 Timeline TRDA ENTRADA THERAPEUTICS INC More: the full row for ENTRADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 584,955 shares; 2025Q1: 584,955 shares; 2025Q2: 584,955 shares; 2025Q3: 584,955 shares; 2025Q4: 2,088,392 shares; 2026Q1: 2,287,500 shares; 2026Q2: 1,060,230 shares; 2026Q3: 1,060,230 shares 1,060,230 $6.73M 0.19% 0 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 406,786 shares; 2026Q2: 406,786 shares; 2026Q3: 406,786 shares 406,786 $6.24M 0.18% 0 Timeline AGEN AGENUS INC More: the full row for AGENUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 603,892 shares 603,892 $6M 0.17% new Timeline OCUL OCULAR THERAPEUTIX INC More: the full row for OCULAR THERAPEUTIX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,319,148 shares; 2025Q1: 5,319,148 shares; 2025Q2: 5,319,148 shares; 2025Q3: 6,117,232 shares; 2025Q4: 5,740,231 shares; 2026Q1: 1,647,752 shares; 2026Q2: 1,647,752 shares; 2026Q3: 720,323 shares 720,323 $5.52M 0.16% -927,429 Timeline ARVN ARVINAS INC More: the full row for ARVINAS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 1,617,365 shares; 2025Q4: 2,666,216 shares; 2026Q1: 2,387,461 shares; 2026Q2: 707,098 shares; 2026Q3: 707,098 shares 707,098 $5.47M 0.15% 0 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 416,301 shares; 2025Q4: 416,301 shares; 2026Q1: 416,301 shares; 2026Q2: 416,301 shares; 2026Q3: 416,301 shares 416,301 $4.13M 0.12% 0 Timeline RACD RESEARCH ALLIANCE CORP IV More: the full row for RESEARCH ALLIANCE CORP IV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000 $3.6M 0.1% new Timeline ALXO ALX ONCOLOGY HLDGS INC More: the full row for ALX ONCOLOGY HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,011,849 shares; 2026Q2: 5,655,487 shares; 2026Q3: 2,465,436 shares 2,465,436 $3.43M 0.1% -3,190,051 Timeline AKTS AKTIS ONCOLOGY INC More: the full row for AKTIS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 696,560 shares; 2026Q3: 133,457 shares 133,457 $2.6M 0.07% -563,103 Timeline JATT JATT II ACQUISITION CORP More: the full row for JATT II ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 200,000 shares; 2026Q3: 200,000 shares 200,000 $2.25M 0.06% 0 Timeline LONA LEONABIO INC More: the full row for LEONABIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 464,398 shares; 2026Q1: 464,398 shares; 2026Q2: 464,398 shares; 2026Q3: 464,398 shares 464,398 $1.66M 0.05% 0 Timeline JTTT JATT III ACQUISITION CORP More: the full row for JATT III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000 $1.1M 0.03% new Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,682,696 shares; 2026Q2: 2,682,696 shares; 2026Q3: 2,682,696 shares 2,682,696 $806K 0.02% 0 Timeline EIKN EIKON THERAPEUTICS INC More: the full row for EIKON THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 37,902 shares; 2026Q3: 37,902 shares 37,902 $305K 0.01% 0 Timeline